Online inquiry

IVTScrip™ mRNA-Human ANKRD31, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK14917MR)

This product GTTS-WK14917MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ANKRD31 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001164443.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 256006
UniProt ID Q8N7Z5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD31, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK14917MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25023MR IVTScrip™ mRNA-Human ARID2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARID2
GTTS-WK28543MR IVTScrip™ mRNA-Human APPL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA APPL1
GTTS-WK18224MR IVTScrip™ mRNA-Human ANKRD39, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD39
GTTS-WK27802MR IVTScrip™ mRNA-Human ASCC1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ASCC1
GTTS-WK8774MR IVTScrip™ mRNA-Human ABI2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABI2
GTTS-WK20236MR IVTScrip™ mRNA-Human alpha-Sarcoglycan, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA alpha-Sarcoglycan
GTTS-WK13092MR IVTScrip™ mRNA-Human ADAM19, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAM19
GTTS-WK25039MR IVTScrip™ mRNA-Human ARL2BP, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL2BP
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →